| Time | Topic | Speaker | Moderator |
| 08:00 – 08:40 | Registration | | |
| 08:40 – 08:50 | Opening Remarks | Dr. Yu Hu | Dr. Zhijian Xiao |
| Advancements in MPN Treatment and Diagnosis |
| 09:00 – 09:25 | MPN Updates and the Evolution of the Diseases | Dr. Ruben Mesa | Dr. Zhijian Xiao
Dr. Sung-Yong Kim |
| 09:25 – 09:50 | A Paradigm Shift in The Diagnosis and Treatment of MPNs, Sooner Better than Later? | Dr. Hans Hasselbalch |
| 09:50 – 10:15 | The Paradigm Shift of Treatment Goals for Polycythemia Vera | Dr. Minghui Duan |
| 10:15 – 10:30 | Coffee Break |
| Exploring Polycythemia Vera and Ropeginterferon Alfa-2b |
| 10:30 – 10:55 | Understanding the Biology of Polycythemia Vera and Changes in Treatment Approaches | Dr. Josef Prchal | Dr. Lei Zhang
Dr. Qian Jiang
Dr. Katsuto Takenaka |
| 10:55 – 11:20 | Moving Toward Disease Modification in Polycythemia Vera | Dr. Raajit Rampal |
| 11:20 – 11:45 | Ropeginterferon Alfa-2b Demonstrates Long-Term Disease Improvements in Polycythemia Vera | Dr. Jean-Jacques Kiladjian |
| 11:45 – 12:10 | Clinical Experience of Ropeginterferon Alfa-2b for PV Treatment | Dr. Prithviraj Bose |
| 12:10 – 12:35 | Efficacy and Safety of Ropeginterferon Alfa-2b in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea | Dr. Bing Li |
| 12:35 – 13:30 | Lunch |
| Global Perspectives on Ropeginterferon Alfa-2b and Myelofibrosis |
| 13:30 – 13:55 | Recent Progress of Ropeginterferon Alfa-2b Clinical Studies in Japan | Dr. Keita Kirito | Dr. Jie Jin
Dr. Xylina Gregg
Dr. Kazuya Shimoda
Dr. Bor-Sheng Ko |
| 13:55 – 14:20 | Treatment with Ropeginterferon Alfa-2b in Korean Patients with PV | Dr. Sung-Eun Lee |
| 14:20 – 14:45 | Early Intervention in Myelofibrosis | Dr. Abdulraheem Yacoub |
| 14:45 – 15:10 | Clinical and Molecular Genetic Characterization of Myelofibrosis | Dr. Gabriela Hobbs |
| 15:10 – 15:35 | The Challenges and the Future in Myelofibrosis Treatment | Dr. Harry Gill |
| 15:35 – 15:50 | Coffee Break |
| Modern Approaches and Real-World Experience |
| 15:50 – 16:15 | Modern Management of Myelofibrosis | Dr. John Mascarenhas | Dr. Sujiang Zhang
Dr. Chin Hin Ng |
| 16:15 – 16:40 | Real Experience: Prospective Ropeginterferon Alfa-2b Therapy in PV & ET | Dr. Tsewang Tashi |
| 16:40 – 17:05 | Overview on Essential Thrombocythemia | Dr. Hsin-An Hou |
| 17:05 – 17:30 | Real-World Study on Myeloproliferative Neoplasms in Zhejiang Province | Dr. Jian Huang |
| 17:30 – 17:55 | Panel Discussion | Dr. Josef Prchal
Dr. Ruben Mesa
Dr. Abdulraheem Yacoub
Dr. Hans Hasselbalch
Dr. Harry Gill
Dr. Na Xu | Dr. Jean-Jacques Kiladjian
Dr. John Mascarenhas
Dr. Xin Du |
| 17:55 – 18:00 | Closing Remarks | Dr. Zhijian Xiao |